Voloridge Investment Management’s RAPT Therapeutics RAPT Stock Holding History

Voloridge Investment Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,893	Closed	-$233K	–	1230
2025 Q4	$233K	Buy	+6,893	New	+$214K	﹤0.01%	1096
2021 Q1	–	Sell	-2,290	Closed	-$362K	–	1613
2020 Q4	$362K	Buy	+2,290	New	+$498K	﹤0.01%	1189

Voloridge Investment Management's RAPT Position: Q1 2026 in Review

Voloridge Investment Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 6,893 shares — an estimated $233K sold.

Voloridge Investment Management first reported a position in RAPT in Q4 2020 and held it in 2 quarters. The position peaked at $362K in Q4 2020. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Voloridge Investment Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Voloridge Investment Management sold 6,893 RAPT Therapeutics shares in Q1 2026, an estimated $233K.
Voloridge Investment Management first reported a position in RAPT Therapeutics in Q4 2020 and held it in 2 quarters.
Voloridge Investment Management's RAPT Therapeutics position peaked at $362K in Q4 2020.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.